An interventional study of Experimental: GROUP A (GONG'S MOBILIZATION WITH SCAPULAR HIGHLIFTS) and Experimental: GROUP B (GONG'S MOBILIZATION WITHOUT SCAPULAR HIGHLIFTS) in Adhesive Capsulitis, sponsored by University of Management and Technology Sialkot Pakistan. Enrolling by invitation at 3 sites in Pakistan. Open to participants aged 40 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-08-12.
Sponsored by University of Management and Technology Sialkot Pakistan · Not applicable, Interventional, and Treatment
This study aims to compare the effectiveness of Gongs Mobilization with and without scapular High-lift in the management of Adhesive Capsulitis, focusing on specific outcomes like pain, functional outcomes, and work productivity.
This study will be a randomized controlled trial with a sample size of 42 participants, as calculated by the G power tool, with 5 % attrition rate, diagnosed with Adhesive Capsulitis. Subjects will be selected through non-probability convenient sampling based on inclusion and exclusion criteria, and randomly assigned into two groups, with 21 participants in each group. Group A will receive Gong mobilization with scapular high-lift, while Group B will receive Gong mobilization without scapular high-lift, both in conjunction with conventional therapy. Demographic Data will also be collected. Baseline and post-intervention data will be collected using SPADI, NPRS, and a goniometer. Data will be analyzed by using IBM SPSS 26.0. At the same time, the Shapiro-Wilk test will be applied to check normality.
383 studies on the registry are indexed under Bursitis; 111 are open to participants now.
This study's planned enrollment of 42 is close to the median of 44 across 346 interventional studies indexed under Bursitis.
Browse Bursitis studies →University of Management and Technology Sialkot Pakistan is the lead sponsor of 8 studies on the registry; 6 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
GROUP A (GONG'S MOBILIZATION WITH SCAPULAR HIGHLIFTS) containing 21 participants who will be given Gong's mobilization with scapular high lifts for 30 minutes along with the conventional physiotherapy.
Other: Experimental: GROUP A (GONG'S MOBILIZATION WITH SCAPULAR HIGHLIFTS)
GROUP B (GONG'S MOBILIZATION WITHOUT SCAPULAR HIGHLIFTS) containing 21 participants who were given Gong's mobilization without scapular high lifts for 30 minutes along with the conventional physiotherapy
Other: Experimental: GROUP B (GONG'S MOBILIZATION WITHOUT SCAPULAR HIGHLIFTS)
In this technique, the therapist applies a sustained lateral glide to the humeral head while the patient actively performs shoulder elevation or abduction. Scapular high lifting is encouraged during the movement to assist shoulder elevation. The technique is performed within a pain-free range to reduce pain and improve shoulder mobility and functional movement.
Patients received Gong's mobilization without allowing scapular high lifting. The therapist applied a lateral glide to the humeral head while the patient performed pain-free shoulder elevation or abduction. Scapular movement was controlled to avoid compensation, aiming to reduce pain and improve shoulder mobility and function.
NUMERICAL PAIN RATING SCALE (NPRS)
It is a fundamental tool used to evaluate pain intensity and pain tolerance. Subjects can rate their pain from 0 (no pain at all) to 10 (pain as bad as it could be) to check whether the pain is acute or chronic. 42. The test-retest reliability coefficient, the intra-class correlation coefficient (ICC) for NPRS, is 0.74, and the minimal clinically important difference (MCID) is 1.1 points
Time frame: 4 Weeks
SHOULDER PAIN AND DISABILITY INDEX (SPADI)
SPADI is used to assess shoulder discomfort and impairment in patients with shoulder disorders. It consists of 13 items divided into two domains; a sub-scale that measures pain contains 5 items, and the other sub-scale consists of 8 items to assess disability. Every sub-scale has a scoring method that calculates the average (mean) at the end to make a score out of 100. A high score indicates greater impairment or disability, and vice versa. The reliability coefficient, the intra-class correlation, is ≥ 0.89, and its minimal clinically important difference (MCID) is 8 points
Time frame: 4 Weeks
UNIVERSAL GONIOMETERY:
The primary movements of the shoulder include flexion and extension, abduction and adduction, horizontal abduction and adduction, as well as lateral and medial rotation. While these movements are assessed at the glenohumeral joint, they rely on coordinated mobility at the sternoclavicular, acromioclavicular, and scapulothoracic joints41. For shoulder AROM, the reliability coefficient, intra-class correlation (ICC), is 0.53-0.6544. The ICC for PROM ranges from 0.87 to 0.99
Time frame: 4 Weeks
Plan to share: Undecided — IPD may not be shared due to concerns regarding patient confidentiality, data ownership, ethical approvals, and consent limitations, as well as institutional or legal restrictions. Additionally, data may be withheld to protect ongoing analyses or unpublished results, or because the data contain sensitive information that cannot be fully anonymized.
Ran from Mar 2026 to primary completion in Mar 2026, 0 months.
Of 217 non-industry interventional studies with no phase under Bursitis, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 17. This study's 0 months is below that.
Counting every sponsor, half of 217 studies reached it within 10 months; a quarter within 5 and three quarters within 17.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Management and Technology Sialkot Pakistan